|
Re: ZEN-3694 Single Agent Trial Status
|
3
|
Zenith Epigenetics
|
Sep 18, 2017 01:28PM
|
|
Re: ZEN-3694 mCRPC Trial Status
|
2
|
Zenith Epigenetics
|
Oct 26, 2017 10:24AM
|
|
Re: ZEN-3694 in combination with "enzalutamide" in patients with metastatic castration resistant prostate cancer (mCRPC)
|
4
|
Zenith Epigenetics
|
Aug 27, 2021 06:18PM
|
|
Re: ZCC relationship to ZEL!
|
4
|
Zenith Epigenetics
|
Apr 13, 2019 01:53PM
|
|
Re: Zacks SCR Resverlogix Report 12/28/18
|
1
|
Resverlogix Corp.
|
Feb 26, 2019 03:59PM
|
|
Re: Zacks SCR Report 6/14/17
|
2
|
Resverlogix Corp.
|
Jun 18, 2017 11:58AM
|
|
Re: Zacks Buy Ranking
|
4
|
Resverlogix Corp.
|
Nov 04, 2015 12:42PM
|
|
Re: Yet another potential indication: Reduction of drug-seeking behavior
|
4
|
Resverlogix Corp.
|
Oct 26, 2021 06:44PM
|
|
Re: Yes , it seems like a hundred years ago...
|
8
|
Resverlogix Corp.
|
Mar 08, 2021 10:55AM
|
|
Re: Wow! Quite the read!
|
5
|
Resverlogix Corp.
|
May 29, 2021 02:18PM
|
|
Re: Wow! Quite the read!
|
1
|
Resverlogix Corp.
|
May 30, 2021 01:03PM
|
|
Re: Wow! Quite the read!
|
4
|
Resverlogix Corp.
|
May 30, 2021 06:35PM
|
|
Re: Wow – I expect so much more from RVX professionals…
|
1
|
Resverlogix Corp.
|
Jun 09, 2017 11:53AM
|
|
Re: Wow – I expect so much more from RVX professionals…
|
3
|
Resverlogix Corp.
|
Jun 09, 2017 01:25PM
|
|
Re: Wow talk about saying....
|
4
|
Resverlogix Corp.
|
Oct 31, 2019 08:05PM
|
|
Re: Wouldn’t the timing be great?
|
4
|
Zenith Epigenetics
|
Jun 18, 2019 12:36PM
|
|
Re: Would love to hear “the rest of the story”
|
5
|
Resverlogix Corp.
|
Apr 17, 2018 03:45PM
|
|
Re: Worst Communicating Company in History?
|
2
|
Zenith Epigenetics
|
Jun 13, 2017 01:29PM
|
|
Re: WORLD DIABETES DAY New RVX Blog Post 11/18/15
|
3
|
Resverlogix Corp.
|
Nov 19, 2015 02:23PM
|
|
Re: Wonderful
|
4
|
Resverlogix Corp.
|
Aug 28, 2017 08:48PM
|
